Deutsch English Français

Contact

EP2202315

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2202315

EP2202315 - Modified vaccinia ankara virus variant [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 08.01.2016 Database last updated on 20.09.2024
Most recent event Tooltip	08.01.2016	Application deemed to be withdrawn	published on 10.02.2016 [2016/06]
Applicant(s)	For all designated states Bavarian Nordic A/S Bøgeskovvej 9 3490 Kvistgaard / DK
	[N/P]
Former [2010/26]	For all designated states Bavarian Nordic A/S Bögeskovvej 9 3490 Kvistgaard / DK
Inventor(s)	01 / Chaplin, Paul Bürgerstrasse 9 81925 München / DE
	02 / Howley, Paul 9 Sing Cressent Berwick, VIC 3806 / AU
	03 / Meisinger-Henschel, Christine Franz-Schuster-Strasse 23A 82061 Neuried / DE
	[2010/38]
Former [2010/26]	01 / Chaplin, Paul Bürgerstrasse 9 81925 München / DE
	02 / Howley, Paul 60 Rose Avenue Glen Waverly, Victoria 3150 / AU
	03 / Meisinger-Henschel, Christine Kreuzackerweg 1 82061 Neuried / DE
Representative(s)	Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE
	[N/P]
Former [2010/26]	Vossius & Partner Siebertstrasse 4 81675 München / DE
Application number, filing date	10158051.2	22.11.2001
	[2010/26]
Priority number, date	DK20000001764	23.11.2000 Original published format: DK 200001764
	[2010/26]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP2202315
	Date:	30.06.2010
	Language:	EN
	[2010/26]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	27.05.2010
Classification	IPC:	C12N15/863, C12N15/39, C12N7/04, C12N5/10, A61K39/285, A61K48/00	[2010/26]
	CPC:	C07K14/005 (EP,NO,US); A61K39/275 (NO); C12N7/04 (KR); A61K39/12 (EP,US); A61K39/285 (EP,NO,US); A61K48/00 (EP,NO,US); (+) A61P31/00 (EP); A61P31/04 (EP); A61P31/12 (EP); A61P31/14 (EP); A61P31/16 (EP); A61P31/18 (EP); A61P31/20 (EP); A61P33/02 (EP); A61P35/00 (EP); A61P37/04 (EP); A61P43/00 (EP); C12N15/86 (EP,NO,US); C12N7/00 (EP,NO,US); A61K2039/5254 (EP,NO,US); A61K2039/5256 (EP,NO,US); A61K2039/53 (EP,NO,US); A61K2039/545 (EP,NO,US); C12N2710/24121 (EP,NO,US); C12N2710/24143 (EP,NO,US); C12N2740/16322 (EP,NO,US) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2010/26]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	Variante des modifizierten vaccinia ankara Virus	[2010/26]
	English:	Modified vaccinia ankara virus variant	[2010/26]
	French:	Variant modifié du virus de la vaccine ankara	[2010/26]
Biological material	This application mentions deposited biological material, check the file for details
Examination procedure	29.12.2010	Amendment by applicant (claims and/or description)
	30.12.2010	Examination requested [2011/07]
	23.05.2011	Despatch of a communication from the examining division (Time limit: M06)
	02.12.2011	Reply to a communication from the examining division
	23.02.2015	Despatch of a communication from the examining division (Time limit: M06)
	08.09.2015	Application deemed to be withdrawn, date of legal effect [2016/06]
	02.10.2015	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/06]
Parent application(s) Tooltip	EP01991753.3 / EP1335987
	EP05017694.0 / EP1598425
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010991753) is 17.02.2004
Fees paid	Renewal fee
	26.03.2010	Renewal fee patent year 03
	26.03.2010	Renewal fee patent year 04
	26.03.2010	Renewal fee patent year 05
	26.03.2010	Renewal fee patent year 06
	26.03.2010	Renewal fee patent year 07
	26.03.2010	Renewal fee patent year 08
	26.03.2010	Renewal fee patent year 09
	30.11.2010	Renewal fee patent year 10
	23.11.2011	Renewal fee patent year 11
	13.11.2012	Renewal fee patent year 12
	18.11.2013	Renewal fee patent year 13
	10.11.2014	Renewal fee patent year 14
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XI]WO9702355 (GSF FORSCHUNGSZENTRUM UMWELT [DE], et al) [X] 1-5,15 * page 4, line 1 - line 21 * * page 8, paragraphs 4,5 * * figure 1 * [I] 6,17;
		[A]US5789245 (DUBENSKY JR THOMAS W [US], et al) [A] 1-17* column 75, line 61 - column 76, line 31 *;
		[XI]WO9907869 (UNIV FLORIDA [US], et al) [X] 1-5,15 * the whole document * [I] 6,17;
		[XI] - CARROLL M W ET AL, "Host Range and Cytopathogenicity of the Highly Attenuated MVA Strain of Vaccinia Virus: Propagation and Generation of Recombinant Viruses in a Nonhuman Mammalian Cell Line", VIROLOGY, (19971124), vol. 238, no. 2, ISSN 0042-6822, pages 198 - 211, XP004460124 [X] 1,15 * the whole document * [I] 6,17 DOI: http://dx.doi.org/10.1006/viro.1997.8845
		[XI] - SUTTER G ET AL, "NONREPLICATING VACCINIA VECTOR EFFICIENTLY EXPRESSES RECOMBINANT GENES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, (19921101), vol. 89, ISSN 0027-8424, pages 10847 - 10851, XP001036843 [X] 1-5,15 * the whole document * [I] 6,17 DOI: http://dx.doi.org/10.1073/pnas.89.22.10847
	by applicant	US5185146
		WO0168820
		- MAYR, A. ET AL., INFECTION, (1975), vol. 3, pages 6 - 14
		- MEYER, H. ET AL., J. GEN. VIROL., (1991), vol. 72, pages 1031 - 1038
		- MAYR, A. AND DANNEN K., DEV. BIOL. STAND., (1978), vol. 41, pages 225 - 234
		- MAYR, ZBL. BAKT. HYG. I, A BT. ORG. B, (1987), vol. 167, pages 375 - 390
		- STICKL ET AL., DTSCH. MED. WSCHR., (1974), vol. 99, pages 2386 - 2392
		- SUTTER, G. ET AL., VACCINE, (1994), vol. 12, pages 1032 - 1040
		- BLANCHARD ET AL., J GEN VIROL, (1998), vol. 79, pages 1159 - 1167
		- CARROLL; MOSS, VIROLOGY, (1997), vol. 238, pages 198 - 211
		- AMBROSINI ET AL., J NEUROSCI RES, (1999), vol. 55, no. 5, page 569
		- BOUKAMP ET AL., J CELL BIOL, (1988), vol. 105, no. 3, pages 761 - 771
		- BOUKAMP ET AL., J CELL BIOL, (1988), vol. 106, no. 3, pages 761 - 771
		- SCHNEIDER ET AL., NAT. MED., (1998), vol. 4, pages 397 - 402
		- THOMSON ET AL., J. IMMUNOL., (1988), vol. 160, page 1717
		- STICKL, H. ET AL., DTSCH. MED. WSCHR., (1974), vol. 99, pages 2386 - 2392
		- KAERBER, G., ARCH. EXP. PATHOL. PHARMAKOL., (1931), vol. 162, page 480
		- THOMSON, J. IMMUNOL., (1998), vol. 160, page 1717
		- THOMSON ET AL., J. IMMUNOL., (1998), vol. 160, page 1717
		- ROSENWIRTH, B ET AL., J VIROL, (2000), vol. 74, page 170411
		- ANKARA. NAT. MED., vol. 4, pages 397 - 402
		- THOMSON ET AL., "Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination", J. IMMUNOL., (1998), vol. 160, page 1717
		WO1996EP02926
		WO2001EP02703

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p